A Bridge to Commercialisation - Part 1

The MTPConnect Podcast

#Science #Fitness #Medicine #MTPConnect #Medtech #Pharma #Biology #Entrepreneur #Business #Health and Well-Being #Industries #Health Innovation #Medical Products #Biotech #Medical Innovation #Biotechnology #Medical Technologies #Life Sciences #RD In

43:52

Episode web page: https://bit.ly/46shU5A ----------------------- Episode summary: Joe Pulizzi—bestselling author, founder of the Content Marketing Institute, and creator of the Content Inc model—joins host Nathan Isaacs to talk about redefining work, meaning, and success in the age of AI and economic uncertainty. From his transition after a successful business exit to founding The Tilt and launching Creator Economy Expo , Joe shares how content creation can unlock personal freedom and lasting impact. He discusses themes from his latest book, Burn the Playbook , and why now is the time for marketers and creators to lean into their unique edge—what he calls your “tilt.” What you’ll learn in this episode: Why marketers have all the skills needed to become entrepreneurs How to find and refine your “tilt” to stand out in a crowded digital space The difference between passion and monetizable expertise Why building an owned audience is more sustainable than relying on social platforms How to create meaningful work that aligns with your life goals—not just your job title Why Joe believes the best time to start is always right now Memorable quote: “Create before you consume. If you do that every day for 30 days, it will change your life.” — Joe Pulizzi Resources & Links: JoePulizzi.com ( https://www.joepulizzi.com/ ) Burn the Playbook ( https://www.joepulizzi.com/books/burn-the-playbook/ ) The Tilt newsletter (https://www.joepulizzi.com/signup/) [Creator Economy Expo (CEX)](https://www.creatoreconomyexpo.com) This Old Marketing podcast (https://www.thisoldmarketing.com/) Content Inc podcast Nathan Isaacs on LinkedIn (https://www.linkedin.com/in/nathanisaacs/) Learn more about Insights Unlocked: https://www.usertesting.com/podcast…

3 года назад 28:20

MP3•Главная эпизода

Back in May 2019, MTPConnect launched the Biomedical Translation Bridge (BTB) program, a $22.3 million initiative of the Medical Research Future Fund, supporting the translation of new therapies, technologies and medical devices through to the proof-of-concept stage. In a first for Australia, it did that by pairing funded projects with industry mentors and commercialisation experts.

Three years on and a COVID-19 pandemic later and the program is now moving to completion. To celebrate this milestone, we brought together the 21 funded projects and our venture and education partners, Biocurate, UniQuest, Medical Device Partnering Program and the Bridge and BridgeTech programs, for the BTB Finale event at Luna Park in Sydney.

In part one of this episode, hosts Caroline Duell and Dr Duncan Macinnis walk the floor catching up with awardees, guests and partners including MTPConnect Chair Sue MacLeman, NSW Parliamentary Secretary for Science, Innovation and Technology Robyn Preston MP. You will hear from some of the team - Prof Jason Monty, Samantha Bates and Kevin - behind the Medihood McMonty, a patient isolation hood developed to protect healthcare workers from COVID-19 now being used in hospitals in Australia and internationally. The BTB program’s support and funding helped move the medical device from research to market. And Dr Andrew Milligan from the Medical Device Partnering Program explains how they provide expertise and guidance to projects like the Medihood to boost the chances of commercial success.

201 эпизодов

A Bridge to Commercialisation - Part 1

The MTPConnect Podcast

26 subscribers

published 3 года назад

MP3•Главная эпизода

201 эпизодов

Все серии

The MTPConnect Podcast

1
Introducing Western Australia’s New Chief Scientist Professor Sriram 38:15

20 дней назад38:15

38:15

Professor Sharath Sriram was recently appointed as the new Chief Scientist of WA, providing independent, expert advice to the WA Government on topics important to the future of science and technology in the State. At our WA Life Sciences Innovation Hub’s Spotlight event he joined MTPConnect’s Dr Tracey Wilkinson for a fireside chat sharing his vision for science and technology in WA, his ambitions for the three years ahead, and insights from his first few months in the role. Accomplished nanotech researcher and commercialisation champion, Professor Sharath spent 16 years at RMIT University in Melbourne most recently as director of the Discovery to Device manufacturing facility. In the last two years he also co-founded healthtech startups Fragment BioTech and Lubdub AI, and is the current president of the national peak body, Science & Technology Australia.…

The MTPConnect Podcast

1
Why Space Matters for Advancing Life Sciences Research 50:00

5 weeks назад50:00

50:00

To mark our 200th episode, we are taking you into Space to discover the benefits of microgravity for health and medical research and its real-world applications. Can we use space technology to advance medical discoveries to improve health here on earth? And should we be doing more to connect our life science sector innovators into Australia’s space research sector? We meet leading Australian superstars working at the intersection of space and health technologies at MTPConnect SA’s Insights Series event “What’s Your Place in Space’, celebrating Australian Space Week in Adelaide. Australia’s first astronaut, Katherine Bennell-Pegg , Director of Space Technology at the Australian Space Agency shares her view on why space matters, and the role of astronauts on the International Space Station as scientists in space. She reveals how biotech research in space using microgravity is revolutionising pharmaceutical development and unlocking treatments for cancer here on Earth. Aerospace medicine specialist Dr Gordon Cable from Human Aerospace , is working on a spacesuit design program, developing compression garments that "trick" the body into thinking gravity exists, with applications for burns, lymphedema and post-surgical recovery. Dr Richard Harvey from the ARC Centre of Excellence in Plants for Space explains how the international research consortium is engineering smart plants in space labs, that operate as programmable biological factories for biomolecule synthesis, to produce pharmaceuticals, including compounds that protect against radiation and improve cancer therapies. And Tiffany Sharp from Cambrian Defence and Space discusses launching medical research into space on a rocket in the Arctic circle - looking into the gut microbiome which shows how certain bacteria affecting anxiety and depression decline in microgravity, offering insights for mental health treatments.…

The MTPConnect Podcast

1
Bio Bites: Doing Business in Boston 25:14

9 weeks назад25:14

25:14

As the world’s largest biotech partnering event took place in Boston in June, MTPConnect was there introducing an Australian delegation to the Boston ecosystem, hosting business events to drive international collaborations and leading the Australian Pavilion to highlight Australia's fast-growing life sciences sector to the international biotech industry. Our CEO Stuart Dignam was on the ground to find out why people are making the trip to BIO and what the buzz is all about. In this episode, Stuart speaks to Brent Owens, co-founder of Ballarat-based Vitrafy Life Sciences – a company pioneering cryopreservation technology and Brent Barnes, CEO and Manager Director of Adelaide-based Clever Culture Systems - inventor of APAS Independence, an intelligent microbiology culture plate reading technology that is revolutionising pharmaceutical lab work. These Australian start-ups have established a foothold in the US and are looking to expand and navigate the new tariff regime. Stuart also catches up with Professor Chris Molloy from the UK’s Medicines Discovery Catapult to get his take on BIO and find out more about the BIOBridge initiative and why collaboration is key to solving the world’s health challenges. For the support and partnership, MTPConnect would like to thank the state governments of NSW, Victoria, Queensland, Western Australia and South Australia, and the Department of Industry, Science and Resources, Austrade, CSIRO and AusBiotech. And thanks for the industry support from Moderna, Novartis, Australia & New Zealand, Cytiva, Sanofi, Arrotex Pharmaceuticals and Nutromics, and support for MTPConnect’s Australian delegation site visit program from CSL and Global Pharma Solutions.…

The MTPConnect Podcast

1
Fast, Fearless and Future - Showcasing Research Excellence for Queensland Health 42:53

10 weeks назад42:53

42:53

Queensland Health is one of the largest employers in the state with some 130,000 full-time employees, geographically dispersed with 16 hospitals and health services across the country. The Office of Research and Innovation (ORI) hosts the ‘Queensland Health Research Excellence Showcase’ to celebrate how translating research into practice is advancing medical research, workforce development and healthcare. The Showcase’s theme - Fast, Fearless and Future – is a unique opportunity for Queensland Health employees to promote their translation-ready research. MTPConnect partnered with ORI to deliver a research poster and pitch session for the Showcase – attracting more than 40 entries from across Queensland. In this episode, we head to Brisbane for the Showcase event to meet some of Queensland Health’s research champions working on major healthcare challenges in mental health, kidney disease, hand therapy, pain education and diabetes-related ulcer care, to find out more about their posters – Dr Mike Trott (University of Queensland), Emma Taylor (STARS Hospital), Hannah Kennedy (Gold Coast Health), Ifeoluwapo Tokun (Townsville Hospital and Health Service) and Margie Conley (Metro South Hospital and Health Service). And Tammy Sovenyhazi Acting Executive Director, Queensland Health’s Office of Research and Innovation, explains what the Showcase is all about! NB. Findings from Dr Trott’s research were recently published internationally in a world first in The Lancet Psychiatry journal https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00129-4/abstract…

The MTPConnect Podcast

1
Laronix Breakthrough Smart Wearable Voicebox is Changing Lives 39:50

14 weeks назад39:50

39:50

Medical device innovator Laronix aims to give people who have had their larynx removed due to laryngeal cancer, their voice back. And not a robotic voice, but a natural sounding voice for both men and women where even laughing and singing is possible. The pioneering company has worked with speech pathologists and surgeons around the world to develop the world’s first smart, wearable (non-invasive), electronic voice box - the first new voice technology in forty years! It uses the power of AI and a person’s respiration signals to generate a natural-sounding voice. In this episode, we meet Laronix co-founder siblings, CEO Dr. Farzaneh Ahmadi and Chief Operating Officer Dr. Mousa Ahmadi, who share their success story, creating a Brisbane-based manufacturing site, expanding to New York, launching their voicing devices in Australia and the US, and changing the lives of those living with a voice disability and giving hope to cancer survivors (half a million people around the world live with this condition). Tune into hear a Laronix voice in action! Dr Farzaneh Ahmadi, an expert in artificial voice research, was named as one of Australia’s top 100 Innovators in The Australian in 2024.…

The MTPConnect Podcast

1
Nurturing your Clinical Innovation with AUSCEP 17:01

16 weeks назад17:01

17:01

In a special series dedicated to the Australian Clinical Entrepreneur Program (AUSCEP) we introduce you to some of the passionate health professionals taking part in this 12-month program to develop their innovative ideas into products and enterprises. Ibrahim Samaan is a senior physiotherapist and Managing Director of Purifas, an award-winning company developing and manufacturing clinically proven hygienic products for allied healthcare - like its FaceShield - now available in Australia, New Zealand, Hong Kong, Japan and the UK. The company is now branching out to develop a new innovation - Recyclable Single-use Hospital Bed Linen for hospitals and the aged care sector. Ibrahim shares his company’s journey and how being part of AUSCEP with like-minded innovators was important in nurturing his entrepreneurship and business acumen. The program’s third cohort has been delivered in NSW and Victoria, in partnership with MTPConnect and Australian Society for Medical Entrepreneurship and Innovation (ASME) and supported by LaunchVic and NSW Agency for Clinical Innovation (ACI). The next 2025/26 cohort is open for Victorian applications until 20 June 2025 – apply at auscep.au . This episode is hosted by MTPConnect’s Caroline Duell and Elizabeth Stares.…

The MTPConnect Podcast

1
Nurturing your Clinical Innovation with AUSCEP 18:57

18 weeks назад18:57

18:57

In a special series dedicated to the Australian Clinical Entrepreneur Program (AUSCEP) we introduce you to some of the passionate health professionals taking part in this 12-month program to develop their innovative ideas into products and enterprises. Dr Monica Hadges is a Clinical Educator and Mental Health Therapist and founder of Mi Team Mental Health. Monica’s digital health innovation, I-CiE Mi Team, is an app for client involved e-collaboration giving consumers and families easy access to participate in clinical review dialogues about their care. Monica shares her start-up journey which began with the findings of her PhD research, and her innovation is now ready for funding to resource further development. She explains how the regular AUSCEP Pitstop events enabled her to find the time away from her busy practice and build camaraderie with other clinicians ‘seeking solutions’. The program’s third cohort has been delivered in NSW and Victoria, in partnership with MTPConnect and Australian Society for Medical Entrepreneurship and Innovation (ASME) and supported by LaunchVic and NSW Agency for Clinical Innovation (ACI). The next 2025/26 cohort is open for Victorian applications until 20 June 2025 – apply at auscep.au . This episode is hosted by MTPConnect’s Caroline Duell and Elizabeth Stares.…

The MTPConnect Podcast

1
Nurturing your Clinical Innovation with AUSCEP 21:54

19 weeks назад21:54

21:54

In a special series dedicated to the Australian Clinical Entrepreneur Program (AUSCEP) we introduce you to some of the passionate health professionals taking part in this 12-month program to develop their innovative ideas into products and enterprises. Dr Yagiz Aksoy is a Resident Doctor at Royal North Shore Hospital in Sydney and co-founder and Director of EosGene Therapeutics, a startup developing a pioneering light-activated gene therapy for diabetic retinopathy and macular degeneration using proprietary drug delivery technology – removing the need for painful eye injections. Yagiz explains how taking part in AUSCEP helped him shift from being a clinician researcher to becoming a translational founder, giving him the language and tools to navigate startup strategy. And it gifted him a community of clinicians trying to solve real problems in different ways. The program’s third cohort has been delivered in NSW and Victoria, in partnership with MTPConnect and Australian Society for Medical Entrepreneurship and Innovation (ASME) and supported by LaunchVic and NSW Agency for Clinical Innovation (ACI). The next 2025/26 cohort is open for Victorian applications until 20 June 2025 – apply at auscep.au. This episode is hosted by MTPConnect’s Caroline Duell and Elizabeth Stares.…

The MTPConnect Podcast

1
Nurturing your Clinical Innovation with AUSCEP 15:34

20 weeks назад15:34

15:34

In a special series dedicated to the Australian Clinical Entrepreneur Program (AUSCEP) we introduce you to some of the passionate health professionals taking part in this 12-month program to develop their innovative ideas into products and enterprises. Elleesha King is a registered nurse and ambulance paramedic, and founder of Pulsatile Innovations, a start-up developing a medical device called Pulse Tile™ to reduce delays to CPR and defibrillation. She takes us on the journey of turning her idea into reality and explains how taking part in AUSCEP and meeting like-minded entrepreneurs has paid off in spades. www.thepulsetile.com The program’s third cohort has been delivered in NSW and Victoria, in partnership with MTPConnect and Australian Society for Medical Entrepreneurship and Innovation (ASME), and supported by LaunchVic and NSW Agency for Clinical Innovation (ACI). The next 2025/26 cohort is open for Victorian applications until 20 June 2025 – apply at auscep.au This episode is hosted by MTPConnect’s Caroline Duell and Elizabeth Stares.…

The MTPConnect Podcast

1
Profile Media: Telling Your Start-Up Story 36:38

23 weeks назад36:38

36:38

From scientific breakthrough to compelling headline - how do medtech and biotech start-ups developing new medical products tell their stories to attract investors, partners and public attention? Profile Media hosted a development workshop for a group of medtech startups through MTPConnect’s Clinical Translation and Commercialisation Medtech accelerator program…helping innovation companies develop a story that goes beyond complex science and is relatable to mainstream media and investors. Sue Papadoulis is a journalist and founder of Profile Media and joins the podcast to share some valuable insights on how start-ups can develop a compelling public profile and effectively communicate their innovation journey – taking a medical innovation from unknown to unforgettable.…

The MTPConnect Podcast

1
FDA to Z of Getting Your Product to the US 33:40

26 weeks назад33:40

33:40

Jeff Gibbs is a Director at Hyman Phelps and McNamara – the largest law firm specialising in FDA issues, based in Washington DC. With four decades of FDA expertise he delivers crucial insights for medical technology companies aiming to crack the US market. Peaking to the podcast during his national tour for the MTPConnect seminar series, this US-based regulatory veteran shares his strategic tips on the FDA submission process, and discusses the dramatically shifting FDA landscape that could make or break your US market entry strategy. Whether you're developing breakthrough medical technology or refining existing solutions, this episode delivers essential knowledge for anyone considering the US market. Subscribe to the MTP Connect podcast for more insights that will help your innovation journey from bench to bedside to global markets.…

The MTPConnect Podcast

1
Tap into Medical Alley’s Academy Training 22:43

28 weeks назад22:43

22:43

Medical Alley is a powerhouse in global healthcare innovation, connecting startups and Fortune 100 companies to transform healthcare solutions. Headquartered in Minnesota, it’s one of the world’s largest medtech clusters. At the 2024 MedTech Conference in Canada, MTPConnect and Medical Alley renewed an MOU to strengthen collaboration and support for Australian medtech companies looking to expand internationally. Now, Medical Alley is launching a game-changing online training program, Medical Alley Academy, designed to help innovators move into the US market - a great opportunity for Australian companies to tap into. Joining Caroline Duell to talk about this exciting initiative are Medical Alley CEO Roberta (Bobbie) Dresson and MTPConnect CEO Stuart Dignam . What’s in this episode? · How Medical Alley is shaping the future of medtech · The changing trends and challenges in the US medtech ecosystem · All about Medical Alley’s new online Academy training · Key opportunities for Australian medtech companies to expand to the U.S. Tune in for expert insights and actionable advice for taking your medtech innovation global! 🎧✨…

The MTPConnect Podcast

1
Ready to Export Your Medtech to Europe? 20:19

31 weeks назад20:19

20:19

Dive into another episode coming to you from MTPConnect’s Development Workshop Series held recently in Sydney for 52 start-up organisations from around Australia. The 2-day program was a terrific opportunity for companies participating in our Accelerator programs to get ‘investor ready’. Exportia Australia ’s Christelle Damiens , an entrepreneur and award-winning author, shared her insights in the workshop “Accessing Global Markets”. Christelle is described as the go-to person for Australian companies looking to expand into the European market and she shared her methodologies, winning strategies and key learnings from more than 20 years of business development in Europe. Christelle joined host Caroline Duell at the event to discuss the complexities of the European regulatory landscape, some advice on export readiness, and the value of outsourcing sales and marketing to European experts and finding the right distribution partners to help you scale.…

The MTPConnect Podcast

1
Unlocking Intrinsic Value to Get Investor Ready 22:29

33 weeks назад22:29

22:29

This episode is coming to you from MTPConnect’s Development Workshop Series held in Sydney for 52 start-up organisations from around Australia. The 2-day program was a terrific opportunity for companies participating in our Accelerator programs to get ‘investor ready’. Advisory firm Intrinsika’s workshop, ‘ Finding Your Intrinsic Value’, focused on how to reframe a company’s value beyond the financials, by identifying and maximising unique assets and pitching this value to investors . Intrinsika’s Brett Kensett-Smith and Michael Masterson joined host Caroline Duell at the event to discuss the importance of differentiating your company to capture investor attention and nailing a 30 second pitch. They share their list of intrinsic assets to consider including trade secrets and effective brand building and explain how cleverly navigating the patent landscape can make all the difference to companies looking to scale up.…

The MTPConnect Podcast

1
Exploring the Australian Stroke and Heart Accelerator’s High Potential Research Portfolio 34:42

34 weeks назад34:42

34:42

The Australian Stroke and Heart Research Accelerator, established through MTPConnect’s Targeted Translation Research Accelerator for cardiovascular disease and diabetes on behalf the Medical Research Future Fund, is a research centre with a bold vision to deliver new health outcomes in coronary artery disease, heart failure and stroke. Through clinical impact and entrepreneurship, an Australian wide network of academics, institutions, and industry partners are driving a high potential research portfolio and an education and training program with a commercialisation focus. We talk to stroke and heart research experts Professor Geoffrey Donnan AO and Professor Jason Kovacic about the Centre’s groundbreaking work covering various pipeline projects, including BiVACOR’s Total Artificial Heart, advanced tele-robotic thrombectomy technologies and a national research clinical trials register, all aimed at improving health outcomes for Australians. Joining host Caroline Duell is Lauren Kelly, MTPConnect’s Senior Director, Targeted Translation Research Accelerator (TTRA) for diabetes and cardiovascular disease.…

The MTPConnect Podcast

1
Heart and Soul: Dr Daniel Timms on Creating the First Successful Total Artificial Heart 36:53

43 weeks назад36:53

36:53

We meet Dr Daniel Timms, the Australian biomechanical engineer behind BiVACOR who has dedicated his life to developing a titanium Total Artificial Heart (TAH) to restore the lives of people with end-stage heart failure, a disease that impacted his own family. It’s a 25-year quest that has taken him from a PhD at QUT, developing the device with his father in his parent’s kitchen in Queensland, to collaborating with experts around the world and expanding operations to the US on his mission to save lives. In 2024 Daniel made history in Texas, with the first successful implantation of the titanium heart into a patient awaiting a heart transplant, as part of an FDA feasibility study. Since then, several patients have received the heart as a bridge to a heart transplant and now Australian patients will be involved in clinical studies. MTPConnect’s Targeted Translation Research Accelerator program for diabetes and cardiovascular disease, an MRFF initiative, has supported BiVACOR ’s development of a more portable external controller to allow for long-term use with the heart. News of BiVACOR’s innovation has spread around the world as patients have shared their story of second chances after receiving the implant. Now we hear Daniel’s story, how the TAH is designed, his inspiration and approach to innovation, collaborations with NASA and transplant surgeons around the world, his plans to expand operations in Australia and what’s next for the privately held company he has put his heart and soul into as he aims to develop the TAH as a long term device that patients can have for the rest of their lives.…

The MTPConnect Podcast

1
How the UK’s Subscription-Style Model is Improving Access to Much-Needed Antibiotics 17:05

45 weeks назад17:05

17:05

As World Antimicrobial Resistance Awareness Week (WAAW) kicked off around the globe, the Australian Antimicrobial Resistance Network (AAMRNet) was meeting in Canberra to explore how Australia can better support the development of and access to new antimicrobial technologies. Key clinicians, researchers, industry and government representatives gathered to discuss how a subscription-style funding model for new antimicrobials might be adapted to be fit-for-purpose in Australia. It’s an idea turned into reality by the UK’s National Health Service (the NHS) after it successfully piloted a world-first subscription reimbursement model, with the goal to improve access to much needed antibiotics, and at the same time incentivize the pharmaceutical industry to develop new antibiotics to tackle superbugs. David Glover, Assistant Director of Medicines Analysis at NHS England joined the workshop to explain the UK model in detail. Afterwards he had a chat with Caroline Duell for the MTPConnect Podcast about the impetus for this pioneering approach, why paying manufacturers a fixed fee for antimicrobials can boost drug development and why this UK model, which is now being expanded, benefits governments, companies and patients.…

The MTPConnect Podcast

1
New Approaches to Fighting Superbugs – Backing New Treatments and Better Access for Patients with Drug Resistant Infections 31:20

46 weeks назад31:20

31:20

It’s World Antimicrobial Resistance Awareness Week (WAAW) and the theme is "Educate. Advocate. Act now". It’s a yearly global campaign, raising awareness of antimicrobial resistance (AMR) and promoting ways to reduce the spread of drug-resistant infections. To mark the occasion, MTPConnect’s Andrew Bowskill, Co-chair of the Australian Antimicrobial Resistance Network, AAMRNet, and Anne Harris, Managing Director of Pfizer Australia and New Zealand join host Caroline Duell to discuss new approaches to fighting superbugs. Why it needs to be tackled holistically with a ‘One Health’ approach across all sectors, including the environment, animal health and agriculture. They discuss the role of vaccines as the first line of defence, and why a new subscription-style reimbursement model in Australia will help support equitable access to new treatments and restimulate investment in antibiotics R&D to meet future needs. We also find out how the recent upgrade to Pfizer’s manufacturing facility in Melbourne is an important development in the fight against AMR.…

The MTPConnect Podcast

1
Medtech Matters: Australia’s medtech delegation hits North America 33:51

49 weeks назад33:51

33:51

As thousands in the medical technology sector headed to Toronto, Canada for The MedTech 2024 Conference, MTPConnect was making sure that the 18 companies and organisations joining the Australian delegation were given opportunities to showcase their capabilities and make valuable US and international connections with a stopover in the medtech hub of Minnesota, before hitting Toronto. In this podcast special from North America, our MTPConnect CEO Stuart Dignam caught up with Kylle Jordan from Destination Medical Centre at the Mayo Clinic campus in Rochester Minnesota ahead of the Medtech conference to find out more about the 20-year initiative underway to expand the hospital precinct as a global medical care destination. Then it was on to the three-day MedTech Conference. MTPConnect signed an MoU with Medical Alley and Stuart talks with their new president and CEO Roberta Dressen about working together to foster global partnerships in health technology. Stuart was on the ground at the Australian Pavilion and caught up with some of Australia’s medtech movers and shakers including iYarn’s Founder and CEO Lockie Cooke, University of Melbourne’s Principal Research Fellow, Optometry and Vision Sciences, A/Prof Lauren Ayton, Materia Health’s Founder, Dr Emily Zhen as well as the delegation’s major supporter, Global Victoria’s Carolin McCaffrey. The Team Australia delegation was supported by our major sponsor the Victorian Government, through Global Victoria and Invest Victoria, as well as support from NSW Health and AusBiotech.…

The MTPConnect Podcast

1
TTRA Information Session: Funding call for Drugs and Devices Addressing Cardiovascular Disease and Complications of Diabetes 1:08:00

51 weeks назад1:08:00

1:08:00

In July 2024, MTPConnect was selected to deliver a new $28.5 million investment for Drugs and Devices, which builds on the legacy of the inaugural TTRA program. The objective of TTRA Drugs and Devices is to accelerate development and commercialisation of promising drugs and medical devices into products that can reduce the burden of cardiovascular disease and complications of diabetes for patients, carers, families and community. TTRA Drugs and Devices is now calling for Expressions of Interest (EOI), to fund eligible Australian start-ups, spin-outs and SMEs to develop innovative preventative, diagnostic, therapeutic and/or disease management drugs and devices for cardiovascular disease and the complications of diabetes (type 1 and type 2). Guidelines & application information can be found on the TTRA webpage . Submissions close at 16:00 AEDT on Monday 4 November 2024. Hear from MTPConnect's TTRA Team Lauren Kelly, Dr Mana Liao and Dr Erin McAllum as well as experts Kenny Lean from Roche Diagnostics Australia, Dr Perdita Cheshire from CSL and Renza Scibilia from Breakthrough T1D. See the TTRA Drugs and Devices webpage for more information.…

The MTPConnect Podcast

1
Omico: Using Genomics to Accelerate Access to Next Generation Cancer Treatments 39:38

1 year назад39:38

39:38

Omico is leading Australia’s largest cancer genomics initiative –giving 23,000 Australians nationwide with advanced or incurable cancers, access to genomic profiling to detect unique genetic variations in their tumours to identify potential matches to new targeted treatments options. It is opening up new treatment pathways, extending lives and attracting more international trials to Australia. Professor David Thomas, renowned for his groundbreaking work in precision oncology, is the founder and Chief Science and Strategy Officer of Omico - the Australian Genomic Cancer Medicine Centre . In this episode, host Caroline Duell speaks with Professor Thomas to find out more about his mission to open up new treatment options for all cancer patients using genomics, the impact of pan tumour therapies on our healthcare system, and why we need to change the way we look at cancer care and cure right now before more people die unnecessarily.…

The MTPConnect Podcast

1
Biocom California's Mission to Connect Down Under 40:15

1 year назад40:15

40:15

Biocom California is the US state’s advocate for the life sciences industry with a network of over 1700 members. With offices located in San Diego, Los Angeles, San Francisco Bay Area, Sacramento, Washington, D.C, and Tokyo the group is focused on building international collaborations and networks to bring new medicines to patients. MTPConnect recently signed an MoU with Biocom California during a visit to San Diego for the 2024 BIO Convention to strengthen ties between the US and Australian life sciences sector. In this episode, MTPConnect CEO Stuart Dignam joins host Caroline Duell to chat with Co-founder, President and CEO of Biocom California, Joe Panetta, about the Biocom California journey that began more than thirty years ago to advocate for the Californian life science sector, one of the leading innovation hubs in the world. Joe shares his top tips for Australian companies looking to move into the US market and talks about Biocom California’s upcoming Global Life Science Partnering and Investor Conference in February 2025 in La Jolla which will provide an important avenue for companies to connect with investors. Australian biotech companies are encouraged to attend this event!…

The MTPConnect Podcast

1
BIO Bites: Making Global Connections and Collaborations at BIO 2024 (Part 3) 48:15

1 year назад48:15

48:15

Back in June, MTPConnect led the Australian delegation at BIO 2024 in San Diego organising a range of activities to showcase Australia’s innovative life sciences sector to the international biotech industry. With a powerful #TeamAustralia focus and a 500-strong delegation from Australia, BIO2024 was the biggest and best ever! In this BIO Bites episode, hosts Caroline Duell and Stuart Dignam catch up with Australian and global companies, entrepreneurs and researchers doing business at BIO and find out what all the buzz is about at the world's largest biotech partnering event. We take a tour around San Diego’s ecosystem catching up with Rachel Rath from the Blue Knight Initiative at J&J Innovation’s JLABS who are supporting early-stage companies, and Dena Marrinucci from US startup Truvian Health who are working with Planet Innovation on a portable blood testing platform. At the Australian Pavilion we chat with University of Adelaide ’s Prof Mark Hutchinson on defence and the SABRE Alliance and find out how statistics and AI are adding value to the life sciences sector with Adelaide Data Science Centre’s Dr Melissa Humphries. Topelia Australia ’s David Fox talks about their antiviral therapeutic targeting coronavirus infections, Bridgewest Ventures ’ Saum Vahdat explains their investment in drug manufacturing in Australia and Attentive Science Australia ’s Holly Stefl discusses their recent expansion into the clinical trial ecosystem in Australia.…

The MTPConnect Podcast

1
BIO Bites: Doing Business at BIO 2024 (Part 2) 53:17

1 year назад53:17

53:17

Back in June, MTPConnect led the Australian delegation at BIO 2024 in San Diego organising a range of activities to showcase Australia’s innovative life sciences sector to the international biotech industry. With a powerful #TeamAustralia focus and a 500-strong delegation from Australia, BIO2024 was the biggest and best ever! In this BIO Bites episode, hosts Caroline Duell and Stuart Dignam catch up with Australian and global companies, entrepreneurs and researchers doing business at BIO and find out what all the buzz is about at the world's largest biotech partnering event. We take you to the Australian Global VIP Networking and Business Reception held on Coronado Island, as special guest John F Crowley, BIO’s President and CEO, welcomes guests in a very inspirational way and Australia’s Minister for Industry and Science the Hon Ed Husic MP who spearheaded the delegation, makes an address to the global audience to raise Australia’s credentials as a global hub for advanced biomanufacturing and clinical trials. We take in a site visit tour around San Diego’s ecosystem and catch up with Illumina’s Dr Emma Ball about the latest in DNA sequencing technologies enabling research discovery and personalized health. And head to the Australian Pavilion to chat to Pending AI’s David Cardoso about their drug discovery platform enabled by artificial intelligence and quantum mechanics, Gelomics’ Christoph Meinert discusses their 3D cell culture technology for animal-free research and Bellberry’s Kylie Sproston discusses the lure of Australia as an attractive destination for clinical trials.…

The MTPConnect Podcast

1
Australian Centre for Accelerating Diabetes Innovations launches groundbreaking virtual emergency department diabetes service 34:45

1 year назад34:45

34:45

Diabetes affects one in 20 people. An important initiative to set up a ‘virtual’ emergency department designed for people living with diabetes has launched in Melbourne, Victoria during National Diabetes Week, with the aim of preventing unnecessary trips to hospital. The Victorian Virtual Emergency Department-Diabetes Service will be added to the existing Victorian Virtual Emergency Department (VVED) giving patients 24/7 online video access to emergency nurses and doctors. As a world first, this new model of care will add a roster of diabetes specialists on weekend and evening shifts, when diabetes patients are most likely to present to a hospital emergency department. Joining the podcast to talk about this new initiative is endocrinologist Professor Elif Ekinci, Director of Diabetes at Austin Health, Head of Department of Medicine at University of Melbourne, and Director of the Australian Centre for Accelerating Diabetes Innovations(ACADI) . ACADI was established in 2022 through MRFF funding from the Australian Government’s Targeted Translation Research Accelerator (TTRA) program, delivered by MTPConnect. Also joining the discussion is Northern Health’s Dr Loren Sher, an emergency specialist who led development of Australia’s first virtual emergency department model, now operating as a Victorian state-wide service. Loren has been instrumental in working with Elif to get the diabetes service up and running. Hosts are Caroline Duell, MTPConnect’s Director Media and Communications and Lauren Kelly, Senior Director of the TTRA program.…

The MTPConnect Podcast

1
BIO Bites: How AI can boost Australia’s biomedical sector 20:36

1 year назад20:36

20:36

ARM Hub is a technology adoption hub based in Brisbane, with a focus on robotics, AI and design for manufacture for biomedical, energy and defence industries. The not for profit was recently appointed as one of four AI Adopt Centres by the Government to provide a service for SMEs that demonstrates how data and AI can modernise business, build skills and boost productivity. ARM Hub is also leading the Australian Manufacturing Capability Network (AMCN) as an Industry Partner Organisation for the Industry Growth Program to help participating small and medium businesses bring new products and services to market. Podcast host Caroline Duell caught up with ARM Hub’s Chief Operating Officer Samuel Jesuadian at BIO 2024 in San Diego, where MTPConnect and ARM Hub unveiled a joint accelerator to help biomedical companies harness the power of data and artificial intelligence (AI). The Biomedical AI Sprints Accelerator will provide matched funding up to $50,000 to upskill a selected number of high growth companies in the use of AI and data analytics, provide access to affordable data management infrastructure, and create a tech-ready workforce. Find out more about the program and how to apply – EOIs close 30 July 2024. Visit the ARM Hub website.…

The MTPConnect Podcast

1
VitalTrace: Revolutionising Childbirth Monitoring to Keep Mothers and Babies Safe 17:41

1 year назад17:41

17:41

The Clinical Translation and Commercialisation Medtech (CTCM) program aims to boost commercialisation of home-grown medical products. It is delivered by MTPConnect on behalf of the Medical Research Future Fund. WA-based VitalTrace is one of the companies participating in the CTCM program and developing a groundbreaking medical device to revolutionise fetal monitoring during childbirth. The company has set up an Australian-based manufacturing facility, received FDA Breakthrough device designation and will soon start its first clinical trial with mothers and babies. Joining host Caroline Duell on the podcast is Dr Chuong Phan, VitalTrace’s Manufacturing Lead, to share more about the progress and translation of DelivAssure, a unique biosensor innovation. This episode comes to you from a special medtech event held in Melbourne and hosted by MTPConnect’s CTCM program and QUT’s The BridgeTech Program. The Design to Manufacturing Tours brought together a number of medtech startups to visit some of Australia’s leading medical manufacturing operations.…

The MTPConnect Podcast

1
The Challenge: A $5 Million Competition to Reimagine Health Care in Western Australia’s Pilbara Region 32:11

1 year назад32:11

32:11

Back in 2022, the Government of Western Australia issued a global challenge for a world-leading medical research and innovation solution to resolve a pressing problem of health service delivery in the remote Pilbara region. Ten projects were selected as finalists and given 12 months proof of concept funding to deliver their solution on the ground in the Pilbara. With the competition ending in October, the best solution will be selected to take home the $5 million prize supported by WA government’s Future Health Research and Innovation Fund, Rio Tinto and BHP. To give us an update, we catch up with the WA Minister for Medical Research, the Honourable Stephen Dawson MLC and RioTinto’s Dampier Salt General Manager Operations, Laura Thomas. Joining Caroline Duell on the podcast is co-host Dr Tracey Wilkinson, MTPConnect’s Director of Stakeholder Engagement in WA at the WA Life Sciences Innovation Hub. To find out more about The Challenge and the ten finalists visit the website .…

The MTPConnect Podcast

1
Australian Stroke and Heart Research Accelerator – driving clinical impact and entrepreneurship 41:47

1 year назад41:47

41:47

The Australian Stroke & Heart Research Accelerator (ASHRA) was established in early 2022 as part of the Targeted Translation Research Accelerator – a program delivered by MTPConnect for the Medical Research Future Fund. This is a research centre with a difference. Lead by Australia’s foremost heart and stroke researchers, ASHRA is aiming to transform the field of cardiovascular and stroke research in Australia by bringing a new sector-wide focus on clinical impact and entrepreneurship. ASHRA’s Director, Professor Clara Chow in Sydney and ASHRA’s Deputy Director Professor Stephen Nicholls in Melbourne, join host Caroline Duell to discuss why a research accelerator of this kind is needed, how ASHRA’s pioneering model is bringing together a likeminded academic and clinical community to drive change, and how they are collaborating with industry to deliver improved outcomes for Australians. Professor Clara Chow is a distinguished cardiologist and clinical researcher, Professor of Medicine at the University of Sydney and serves as the Academic Director of the Westmead Applied Research Centre. Professor Stephen Nicholls is a world-renowned cardiologist, inaugural Director of the Victorian Heart Institute and a Professor of Cardiology at Monash University. He also leads the Victorian Heart Hospital (VHH) - Australia's first dedicated heart hospital. This is the first episode in series on ASHRA.…

The MTPConnect Podcast

1
From Mines to Medicines - Australia Poised for a Radiopharmaceuticals Revolution 1:58:43

1 year назад1:58:43